Please login to the form below

Not currently logged in
Email:
Password:

evolution

This page shows the latest evolution news and features for those working in and with pharma, biotech and healthcare.

Merck exec steps down, two takes his place

Merck exec steps down, two takes his place

Frazier says he has relied on Schechter’s expertise for the past nine years, crediting the global human health lead with Merck’s commercial evolution, expanding its medicines and vaccines reach

Latest news

  • Generic Differentiation Generic Differentiation

    Some environments are so harsh, they constrain evolution.That’s why, for example, desert and arctic habitats have lower species-richness than tropical forests. ... Professor Brian D Smith is a world-recognised authority on the evolution of the life

  • Regeneron’s early stage bispecific shows promise Regeneron’s early stage bispecific shows promise

    Representing an evolution of the well-established monoclonal antibody platform, bispecifics can hit two or more cell surface targets.

  • The Midas Touch The Midas Touch

    Smart, but small, science can turn old ideas into gold. To a scientist, empirical evidence is everything.It is said that Darwin conceived of evolution by natural selection some 20 years ... Professor Brian D Smith is a world-recognised authority on the

  • Big Pharma, Little Pharma Big Pharma, Little Pharma

    Evolution provides options for those firms that can’t be huge. Our attention tends to focus on what the biggest industry players are doing. ... is a world-recognised authority on the evolution of the life sciences industry.

  • Medtech's mixed-up monsters Medtech's mixed-up monsters

    That’s odd, as Asimov would say. That’s evolution, as Darwin would say. ... Professor Brian D Smith is a world-recognised authority on the evolution of the life sciences industry.

More from news
Approximately 13 fully matching, plus 236 partially matching documents found.

Latest Intelligence

  • Diagnosed Anywhere Diagnosed Anywhere

    Cognoa created a machine-learning app for paediatric behavioural health ‘The tools we adopt in our everyday consumer lives drive an evolution cycle that ultimately changes healthcare expectations’ designed to reduce ... The role of consumer

  • The power of behaviour change lies in the basics The power of behaviour change lies in the basics

    Indicators on the way to behaviour change can include awareness, attitude changes, ‘self-efficacy evolution’ (people’s belief that they have the ability to perform particular behaviours), and behavioural intentions.

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Pipeline and evolution of the RNAi platform. Analysts are agreed that RNA-based therapeutics could, in the long term, revolutionise how many diseases are treated, and Alnylam’s leadership in the

  • Making Europe a leader in bioscience: boosting trust and opening minds Making Europe a leader in bioscience: boosting trust and opening minds

    These are deep structural evolutions, and require established research players to adapt rapidly if they want to remain leaders.

  • The rise of digital comms The rise of digital comms

    The life sciences industry has gone through several phases of commercial evolution, from face-to-face interactions to multichannel engagement to coordinated interactions between commercial and medical teams. ... The next evolution in commercial

More from intelligence
Approximately 2 fully matching, plus 90 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 39 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 47 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics